Drug recall · May 13, 2020
Epinephrine Injection USP recall
Why: CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27
- Lots / codes
Lot # 007F19AA, exp. date 04/2021
- Quantity
- 600 cartons/2 auto-injector per carton
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Product was distributed to 1 wholesaler who still had all units within their possession and had not shipped or further distributed any of the product.
- Initiated
- March 5, 2020 · Voluntary: Firm initiated
- Classified
- May 5, 2020
- Reported
- May 13, 2020
- Ended
- November 19, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.